Mectizan Donation Program | Local power. Global Change.
MERCK A program at The Task Force for Global Health
Switch to French site


Merck Fact Sheet – 2007

31 March 2017 | Topics:
MCT-2007-PA-003-BK (43.79 KB)

Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/ on line 94

Related articles

Scientific Publication

Cross-border issues: an important component of onchocerciasis elimination programmes

Article on the importance of cross-border issues in onchocerciasis elimination programmes. Bush, Sodahlon, Downs and Mackenzie, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i54–i59.

Scientific Publication

Alternative treatment strategies to accelerate the elimination of onchocerciasis

Article on the use of alternative (or complementary) treatment strategies (ATSs) to accelerate the elimination of onchocerciasis. Boussinesq et al., International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i40–i48.

Scientific Publication

After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight

Article on eliminating onchocercias as a public health problem in Uganda. Katabarwa et al, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i79–i88.

Scientific Publication

Diagnostics for onchocerciasis in the era of elimination

A review summarizing the progress made in identifying diagnostics that meet the specialized requirements needed to verify onchocerciasis elimination, as well as a discussion of why these tests were selected and a summary of the needs that still exist to complete the arsenal of diagnostic tools that will be useful as the goal of elimination is achieved. 

Scientific Publication

Establishing quality assured (QA) laboratory support for onchocerciasis elimination in Africa

Article on the acquisition of quality-assured (QA) data that ultimately define the absence of infection or transmission of onchocerciasis in previously endemic areas in Africa. 

Scientific Publication

For as Long as Necessary: Examining 30 years of MSD’s Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis

This article provides an overview of the three decades of dedicated effort Merck & Co., Inc., Kenilworth, N.J., U.S.A.*has put into its donation of Mectizan to assist in achieving the elimination of onchocerciasis and lymphatic filariasis.